Effect of the Tibetan Medicine Zuotai on Degranulation and Inflammatory Mediator Release in RBL-2H3 Cells

Chemical & Pharmaceutical Bulletin
Zhenjiang XiaJing Shang

Abstract

Zuotai is a drug containing mercury considered to be the king of Tibetan medicine. The biosafety of Zuotai led people's attention and so far little is known about the toxicity of Zuotai to mast cells. RBL-2H3 cells which used as an alternative model of mast cells were treated with Zuotai, β-HgS and positive drug Compound 48/80 respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine the toxicity of drugs to RBL-2H3 cells. The degranulation of RBL-2H3 cells was studied from β-hexosaminidase, histamine, interleukin (IL)-4 and tumor necrosis factor-α (TNF-α). The result showed that Zuotai can affect the cytotoxicity and degranulation of RBL-2H3 cells and the results can provide reference for the toxicity evaluations of Tibetan medicine Zuotai.

References

Nov 20, 1986·Journal of Immunological Methods·D Gerlier, N Thomasset
Mar 10, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·E PassanteN Frankish
Mar 21, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Egle PassanteNeil Frankish
Mar 24, 2012·Archives of Toxicology·Sushant U KamathUma Maheswari Krishnan
Sep 26, 2012·Physical Review Letters·M AblikimUNKNOWN BESIII Collaboration
Nov 6, 2012·Food Chemistry·Momoko IshidaTakuya Sugahara
Jul 22, 2015·Drug and Chemical Toxicology·Bo LiLi-Min Li
Jul 10, 2016·Immunology Letters·Anna RizziDomenico Ribatti
Jan 12, 2017·Cytotechnology·Asuka KishikawaKuniyoshi Shimizu

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.